Delivery Order SPE2DB24D1205-SPE2DB25FDAEZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitive award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $24.4K and is structured as a firm fixed price delivery order, with an ultimate completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 Firm Fixed Price Delivery Order contract is for the supply of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the supply of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $24,368.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4568112342 ! AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a period of performance through May 21, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,368.92, is for the delivery of 4568149543 AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has a period of performance through May 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAEZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been competitively awarded this delivery order as part of its established relationship with the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, and other government organizations. This delivery order reflects the company's ongoing role as a prime vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/8/25 |